Paxillin, one of the adaptor molecules critical for integrating the focal adhesion signaling [5–7], is known to be involved in HCC progression triggered by HGF [8, 9], integrin engagement [10] or overexpression of P21-activated protein kinase [11]. This evidence concerns the gene PXN and hepatocellular carcinoma.